# US 2003/0204073 A1 · Non-endogenous, constitutively activated known G protein-coupled receptors

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2003/0204073 A1
- Document ID: US20030204073A1
- Status: Published application
- Kind: A1
- Application number: 09/826,509
- Filed: 2001-04-05
- Published: 2003-10-30
- Earliest claimed: 2000-04-07
- Assignees: Arena Pharmaceuticals, Inc.
- Inventors: Karin Lehmann-Bruinsma; Chen W. Liaw; I-Lin Lin
- Web page: https://patentgrep.com/patent/US20030204073A1

## CPC

- G01N 33/74: involving hormones {or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors}
- C07K 14/705: Receptors; Cell surface antigens; Cell surface determinants {(tumour specific antigens C07K14/4748)}
- C07K 14/723: {G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH receptor}
- A61K 38/00: Medicinal preparations containing peptides (peptides containing beta-lactam rings A61K31/00; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, A61K31/00; ergot alkaloids of the cyclic peptide type A61K31/48; containing macromolecular compounds having statistically distributed amino acid units A61K31/74; medicinal preparations containing antigens or antibodies A61K39/00; medicinal preparations characterised by the non-active ingredients, e.g. peptides as drug carriers, A61K47/00)
- C07K 2319/00: Fusion polypeptide
- G01N 2333/726: G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH
- G01N 2500/10: involving cells
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)

## Abstract

The invention disclosed in this patent document relates to transmembrane receptors, more particularly to a human G protein-coupled receptor for which the endogenous ligand is known (“known GPCRs”), and most particularly to mutated (non-endogenous) versions of the known GPCRs for use, most preferably in screening assays for the direct identification of candidate compounds as inverse agonists, agonists and partial agonists.

## Claims

### Claim 1

A method for directly identifying a non-endogenous compound as a compound having an activity selected from the group consisting of: inverse agonists, parallel agonists, and partial agonists, to a non-endogenous, constitutively activated version of known G protein-coupled receptor, said receptor comprising a transmembrane-6 region and an intracellular region, comprising the steps of:
(a) selecting a non-endogenous version of a known GPCR having an amino acid sequence selected from the group consisting of SEQ.ID.NO.:425;
38 SEQ.ID.NO.:427; SEQ.ID.NO.:429; SEQ.ID.NO.:431; SEQ.ID.NO.:433; SEQ.ID.NO.:435; SEQ.ID.NO.:437; SEQ.ID.NO.:439; SEQ.ID.NO.:441; SEQ.ID.NO.:443; SEQ.ID.NO.:445; SEQ.ID.NO.:447; SEQ.ID.NO.:449; SEQ.ID.NO.:451; SEQ.ID.NO.:453; SEQ.ID.NO.:455; SEQ.ID.NO.:457; SEQ.ID.NO.:459; SEQ.ID.NO.:461; SEQ.ID.NO.:463; SEQ.ID.NO.:465; SEQ.ID.NO.:467; SEQ.ID.NO.:469; SEQ.ID.NO.:471; SEQ.ID.NO.:473; SEQ.ID.NO.:475; SEQ.ID.NO.:477; SEQ.ID.NO.:479; SEQ.ID.NO.:481; SEQ.ID.NO.:483; SEQ.ID.NO.:485; SEQ.ID.NO.:487; SEQ.ID.NO.:489; SEQ.ID.NO.:491; SEQ.ID.NO.:493; SEQ.ID.NO.:495; SEQ.ID.NO.:497; SEQ.ID.NO.:499; SEQ.ID.NO.:501; SEQ.ID.NO.:503; SEQ.ID.NO.:505; SEQ.ID.NO.:507; SEQ.ID.NO.:347; SEQ.ID.NO.:509; SEQ.ID.NO.:351; SEQ.ID.NO.:355; SEQ.ID.NO.:359; SEQ.ID.NO.:363; SEQ.ID.NO.:367; SEQ.ID.NO.:371; SEQ.ID.NO.:375; SEQ.ID.NO.:379; SEQ.ID.NO.:383; SEQ.ID.NO.:387; SEQ.ID.NO.:391; SEQ.ID.NO.:511; SEQ.ID.NO.:513; SEQ.ID.NO.:515; SEQ.ID.NO.:517; SEQ.ID.NO.:519; SEQ.ID.NO.:521; SEQ.ID.NO.:523; SEQ.ID.NO.:525; SEQ.ID.NO.:527; SEQ.ID.NO.:529; SEQ.ID.NO.:531; SEQ.ID.NO.:533; SEQ.ID.NO.:535; SEQ.ID.NO.:537; SEQ.ID.NO.:539; SEQ.ID.NO.:541; SEQ.ID.NO.:543; SEQ.ID.NO.:545; SEQ.ID.NO.:547; SEQ.ID.NO.:549: SEQ.ID.NO.:551; SEQ.ID.NO.:553; SEQ.ID.NO.:555; SEQ.ID.NO.:557; SEQ.ID.NO.:559; SEQ.ID.NO.:561: SEQ.ID.NO.:563: SEQ.ID.NO.:565; SEQ.ID.NO.:567; SEQ.ID.NO.:569; SEQ.ID.NO.:571; SEQ.ID.NO.:573; SEQ.ID.NO.:575; SEQ.ID.NO.:577; SEQ.ID.NO.:395; SEQ.ID.NO.:399; SEQ.ID.NO.:403; SEQ.ID.NO.:407; SEQ.ID.NO.:411; SEQ.ID.NO.:415; SEQ.ID.NO.:419; SEQ.ID.NO.:423; SEQ.ID.NO.:579; and SEQ.ID.NO.:581;
(b) confirming that the selected non-endogenous GPCR of step (a) is constitutively active;
(c) contacting a non-endogenous candidate compound with the non-endogenous, constitutively activated GPCR of step of (b); and
(d) determining, by measurement of the compound efficacy at said contacted receptor, whether said non-endogenous compound having inverse agonist activity as an inverse agonist or agonist activity is an agonist to said receptor of step (b).

### Claim 2 (depends on 1)

The method of claim 1 wherein the non-endogenous GPCR of step (b) is an amino acid sequence having the sequence of SEQ.ID.NO.:425.

### Claim 3 (depends on 1)

The method of claim 1 wherein the non-endogenous GPCR of step (b) is an amino acid sequence having the sequence of SEQ.ID.NO.:427

### Claim 4 (depends on 1)

The method of claim 1 wherein the non-endogenous GPCR of step (b) is an amino acid sequence having the sequence of SEQ.ID.NO.:429.

### Claim 5 (depends on 1)

The method of claim 1 wherein the non-endogenous GPCR of step (b) is an amino acid sequence having the sequence of SEQ.ID.NO.:431.

### Claim 6 (depends on 1)

The method of claim 1 wherein the non-endogenous GPCR of step (b) is an amino acid sequence having the sequence of SEQ.ID.NO.:433.

### Claim 7 (depends on 1)

The method of claim 1 wherein the non-endogenous GPCR of step (b) is an amino acid sequence having the sequence of SEQ.ID.NO.:435.

### Claim 8 (depends on 1)

The method of claim 1 wherein the non-endogenous GPCR of step (b) is an amino acid sequence having the sequence of SEQ.ID.NO.:437.

### Claim 9 (depends on 1)

The method of claim 1 wherein the non-endogenous GPCR of step (b) is an amino acid sequence having the sequence of SEQ.ID.NO.:439.

### Claim 10 (depends on 1)

The method of claim 1 wherein the non-endogenous GPCR of step (b) is an amino acid sequence having the sequence of SEQ.ID.NO.:441.

### Claim 11 (depends on 1)

The method of claim 1 wherein the non-endogenous GPCR of step (b) is an amino acid sequence having the sequence of SEQ.ID.NO.:443.

### Claim 12 (depends on 1)

The method of claim 1 wherein the non-endogenous GPCR of step (b) is an amino acid sequence having the sequence of SEQ.ID.NO.:445.

### Claim 13 (depends on 1)

The method of claim 1 wherein the non-endogenous GPCR of step (b) is an amino acid sequence having the sequence of SEQ.ID.NO.:447.

### Claim 14 (depends on 1)

The method of claim 1 wherein the non-endogenous GPCR of step (b) is an amino acid sequence having the sequence of SEQ.ID.NO.:449.

### Claim 15 (depends on 1)

The method of claim 1 wherein the non-endogenous GPCR of step (b) is an amino acid sequence having the sequence of SEQ.ID.NO.:451.

### Claim 16 (depends on 1)

The method of claim 1 wherein the non-endogenous GPCR of step (b) is an amino acid sequence having the sequence of SEQ.ID.NO.:453.

### Claim 17 (depends on 1)

The method of claim 1 wherein the non-endogenous GPCR of step (b) is an amino acid sequence having the sequence of SEQ.ID.NO.:455.

### Claim 18 (depends on 1)

The method of claim 1 wherein the non-endogenous GPCR of step (b)is an amino acid sequence having the sequence of SEQ.ID.NO.:457.

### Claim 19 (depends on 1)

The method of claim 1 wherein the non-endogenous GPCR of step (b) is an amino acid sequence having the sequence of SEQ.ID.NO.:459.

### Claim 20 (depends on 1)

The method of claim 1 wherein the non-endogenous GPCR of step (b) is an amino acid sequence having the sequence of SEQ.ID.NO.:461.

### Claim 21 (depends on 1)

The method of claim 1 wherein the non-endogenous GPCR of step (b) is an amino acid sequence having the sequence of SEQ.ID.NO.:463.

### Claim 22 (depends on 1)

The method of claim 1 wherein the non-endogenous GPCR of step (b) is an amino acid sequence having the sequence of SEQ.ID.NO.:465.

### Claim 23 (depends on 1)

The method of claim 1 wherein the non-endogenous GPCR of 467.

### Claim 24 (depends on 1)

The method of claim 1 wherein the non-endogenous GPCR of step (b) is an amino acid sequence having the sequence of SEQ.ID.NO.:469.

### Claim 25 (depends on 1)

The method of claim 1 wherein the non-endogenous GPCR of step (b) is an amino acid sequence having the sequence of SEQ.ID.NO.:471.

### Claim 26 (depends on 1)

The method of claim 1 wherein the non-endogenous GPCR of step (b) is an amino acid sequence having the sequence of SEQ.ID.NO.:473.

### Claim 27 (depends on 1)

The method of claim 1 wherein the non-endogenous GPCR of step (b) is an amino acid sequence having the sequence of SEQ.ID.NO.:475.

### Claim 28 (depends on 1)

The method of claim 1 wherein the non-endogenous GPCR of step (b) is an amino acid sequence having the sequence of SEQ.ID.NO.:477.

### Claim 29 (depends on 1)

The method of claim 1 wherein the non-endogenous GPCR of step (b) is an amino acid sequence having the sequence of SEQ.ID.NO.:479.

### Claim 30 (depends on 1)

The method of claim 1 wherein the non-endogenous GPCR of step (b) is an amino acid sequence having the sequence of SEQ.ID.NO.:481.

### Claim 31 (depends on 1)

The method of claim 1 wherein the non-endogenous GPCR of step (b) is an amino acid sequence having the sequence of SEQ.ID.NO.:483.

### Claim 32 (depends on 1)

The method of claim 1 wherein the non-endogenous GPCR of step (b) is an amino acid sequence having the sequence of SEQ.ID.NO.:485.

### Claim 33 (depends on 1)

The method of claim 1 wherein the non-endogenous GPCR of step (b) is an amino acid sequence having the sequence of SEQ.ID.NO.:487.

### Claim 34 (depends on 1)

The method of claim 1 wherein the non-endogenous GPCR of step (b) is an amino acid sequence having the sequence of SEQ.ID.NO.:489.

### Claim 35 (depends on 1)

The method of claim 1 wherein the non-endogenous GPCR of step (b) is an amino acid sequence having the sequence of SEQ.ID.NO.:491.

### Claim 36 (depends on 1)

The method of claim 1 wherein the non-endogenous GPCR of step (b) is an amino acid sequence having the sequence of SEQ.ID.NO.:493.

### Claim 37 (depends on 1)

The method of claim 1 wherein the non-endogenous GPCR of step (b) is an amino acid sequence having the sequence of SEQ.ID.NO.:495.

### Claim 38 (depends on 1)

The method of claim 1 wherein the non-endogenous GPCR of step (b) is an amino acid sequence having the sequence of SEQ.ID.NO.:497.

### Claim 39 (depends on 1)

The method of claim 1 wherein the non-endogenous GPCR of step (b) is an amino acid sequence having the sequence of SEQ.ID.NO.:499.

### Claim 40 (depends on 1)

The method of claim 1 wherein the non-endogenous GPCR of step (b) is an amino acid sequence having the sequence of SEQ.ID.NO.:501.

### Claim 41 (depends on 1)

The method of claim 1 wherein the non-endogenous GPCR of step (b) is an amino acid sequence having the sequence of SEQ.ID.NO.:503.

### Claim 42 (depends on 1)

The method of claim 1 wherein the non-endogenous GPCR of step (b) is an amino acid sequence having the sequence of SEQ.ID.NO.:505.

### Claim 43 (depends on 1)

The method of claim 1 wherein the non-endogenous GPCR of step (b) is an amino acid sequence having the sequence of SEQ.ID.NO.:507.

### Claim 44 (depends on 1)

The method of claim 1 wherein the non-endogenous GPCR of step (b) is an amino acid sequence having the sequence of SEQ.ID.NO.:347.

### Claim 45 (depends on 1)

The method of claim 1 wherein the non-endogenous GPCR of step (b) is an amino acid sequence having the sequence of SEQ.ID.NO.:509.

### Claim 46 (depends on 1)

The method of claim 1 wherein the non-endogenous GPCR of step (b) is an amino acid sequence having the sequence of SEQ.ID.NO.:351.

### Claim 47 (depends on 1)

The method of claim 1 wherein the non-endogenous GPCR of step (b) is an amino acid sequence having the sequence of SEQ.ID.NO.:355.

### Claim 48 (depends on 1)

The method of claim 1 wherein the non-endogenous GPCR of step (b) is an amino acid sequence having the sequence of SEQ.ID.NO.:359.

### Claim 49 (depends on 1)

The method of claim 1 wherein the non-endogenous GPCR of step (b) is an amino acid sequence having the sequence of SEQ.ID.NO.:361.

### Claim 50 (depends on 1)

The method of claim 1 wherein the non-endogenous GPCR of step (b) is an amino acid sequence having the sequence of SEQ.ID.NO.:367.

### Claim 51 (depends on 1)

The method of claim 1 wherein the non-endogenous GPCR of step (b) is an amino acid sequence having the sequence of SEQ.ID.NO.:371.

### Claim 52 (depends on 1)

The method of claim 1 wherein the non-endogenous GPCR of step (b) is an amino acid sequence having the sequence of SEQ.ID.NO.:375.

### Claim 53 (depends on 1)

The method of claim 1 wherein the non-endogenous GPCR of step (b) is an amino acid sequence having the sequence of SEQ.ID.NO.:379.

### Claim 54 (depends on 1)

The method of claim 1 wherein the non-endogenous GPCR of step (b) is an amino acid sequence having the sequence of SEQ.ID.NO.:383.

### Claim 55 (depends on 1)

The method of claim 1 wherein the non-endogenous GPCR of step (b) is an amino acid sequence having the sequence of SEQ.ID.NO.:387.

### Claim 56 (depends on 1)

The method of claim 1 wherein the non-endogenous GPCR of step (b) is an amino acid sequence having the sequence of SEQ.ID.NO.:391.

### Claim 57 (depends on 1)

The method of claim 1 wherein the non-endogenous GPCR of step (b) is an amino acid sequence having the sequence of SEQ.ID.NO.:511.

### Claim 58 (depends on 1)

The method of claim 1 wherein the non-endogenous GPCR of step (b) is an amino acid sequence having the sequence of SEQ.ID.NO.:513.

### Claim 59 (depends on 1)

The method of claim 1 wherein the non-endogenous GPCR of step (b) is an amino acid sequence having the sequence of SEQ.ID.NO.:515.

### Claim 60 (depends on 1)

The method of claim 1 wherein the non-endogenous GPCR of step (b) is an amino acid sequence having the sequence of SEQ.ID.NO.:517.

### Claim 61 (depends on 1)

The method of claim 1 wherein the non-endogenous GPCR of step (b) is an amino acid sequence having the sequence of SEQ.ID.NO.:519.

### Claim 62 (depends on 1)

The method of claim 1 wherein the non-endogenous GPCR of step (b) is an amino acid sequence having the sequence of SEQ.ID.NO.:521.

### Claim 63 (depends on 1)

The method of claim 1 wherein the non-endogenous GPCR of step (b) is an amino acid sequence having the sequence of SEQ.ID.NO.:523.

### Claim 64 (depends on 1)

The method of claim 1 wherein the non-endogenous GPCR of step (b) is an amino acid sequence having the sequence of SEQ.ID.NO.:525.

### Claim 65 (depends on 1)

The method of claim 1 wherein the non-endogenous GPCR of step (b) is an amino acid sequence having the sequence of SEQ.ID).NO.:527.

### Claim 66 (depends on 1)

The method of claim 1 wherein the non-endogenous GPCR of step (b) is an amino acid sequence having the sequence of SEQ.ID.NO.:529.

### Claim 67 (depends on 1)

The method of claim 1 wherein the non-endogenous GPCR of step (b) is an amino acid sequence having the sequence of SEQ.ID.NO.:531.

### Claim 68 (depends on 1)

The method of claim 1 wherein the non-endogenous GPCR of step (b) is an amino acid sequence having the sequence of SEQ.ID.NO.:533.

### Claim 69 (depends on 1)

The method of claim 1 wherein the non-endogenous GPCR of step (b) is an amino acid sequence having the sequence of SEQ.ID.NO.:535.

### Claim 70 (depends on 1)

The method of claim 1 wherein the non-endogenous GPCR of step (b) is an amino acid sequence having the sequence of SEQ.ID.NO.:537.

### Claim 71 (depends on 1)

The method of claim 1 wherein the non-endogenous GPCR of step (b) is an amino acid sequence having the sequence of SEQ.ID.NO.:539.

### Claim 72 (depends on 1)

The method of claim 1 wherein the non-endogenous GPCR of step (b) is an amino acid sequence having the sequence of SEQ.ID.NO.:541.

### Claim 73 (depends on 1)

The method of claim 1 wherein the non-endogenous GPCR of step (b) is an amino acid sequence having the sequence of SEQ.ID.NO.:543.

### Claim 74 (depends on 1)

The method of claim 1 wherein the non-endogenous GPCR of step (b) is an amino acid sequence having the sequence of SEQ.ID.NO.:545.

### Claim 75 (depends on 1)

The method of claim 1 wherein the non-endogenous GPCR of step (b) is an amino acid sequence having the sequence of SEQ.ID.NO.:547.

### Claim 76 (depends on 1)

The method of claim 1 wherein the non-endogenous GPCR of step (b) is an amino acid sequence having the sequence of SEQ.ID.NO.:549.

### Claim 77 (depends on 1)

The method of claim 1 wherein the non-endogenous GPCR of step (b) is an amino acid sequence having the sequence of SEQ.ID.NO.:551.

### Claim 78 (depends on 1)

The method of claim 1 wherein the non-endogenous GPCR of step (b) is an amino acid sequence having the sequence of SEQ.ID.NO.:553.

### Claim 79 (depends on 1)

The method of claim 1 wherein the non-endogenous GPCR of step (b) is an amino acid sequence having the sequence of SEQ.ID.NO.:555.

### Claim 80 (depends on 1)

The method of claim 1 wherein the non-endogenous GPCR of step (b) is an amino acid sequence having the sequence of SEQ.ID.NO.:557.

### Claim 81 (depends on 1)

The method of claim 1 wherein the non-endogenous GPCR of step b is step (b) is an amino acid sequence having the sequence of SEQ.ID.NO.:559.

### Claim 82 (depends on 1)

The method of claim 1 wherein the non-endogenous GPCR of step (b) is an amino acid sequence having the sequence of SEQ.ID.NO.:561.

### Claim 83 (depends on 1)

The method of claim 1 wherein the non-endogenous GPCR of step (b) is an amino acid sequence having the sequence of SEQ.ID.NO.:563.

### Claim 84 (depends on 1)

The method of claim 1 wherein the non-endogenous GPCR of step (b) is an amino acid sequence having the sequence of SEQ.ID.NO.:565.

### Claim 85 (depends on 1)

The method of claim 1 wherein the non-endogenous GPCR of step (b) is an amino acid sequence having the sequence of SEQ.ID.NO.:567.

### Claim 86 (depends on 1)

The method of claim 1 wherein the non-endogenous GPCR of step (b) is an amino acid sequence having the sequence of SEQ.ID.NO.:569.

### Claim 87 (depends on 1)

The method of claim 1 wherein the non-endogenous GPCR of step (b) is an amino acid sequence having the sequence of SEQ.ID.NO.:571.

### Claim 88 (depends on 1)

The method of claim 1 wherein the non-endogenous GPCR of step (b) is an amino acid sequence having the sequence of SEQ.ID.NO.:573.

### Claim 89 (depends on 1)

The method of claim 1 wherein the non-endogenous GPCR of step (b) is an amino acid sequence having the sequence of SEQ.ID.NO.:575.

### Claim 90 (depends on 1)

The method of claim 1 wherein the non-endogenous GPCR of step (b) is an amino acid sequence having the sequence of SEQ.ID.NO.:577.

### Claim 91 (depends on 1)

The method of claim 1 wherein the non-endogenous GPCR of step (b) is an amino acid sequence having the sequence of SEQ.ID.NO.:395.

### Claim 92 (depends on 1)

The method of claim 1 wherein the non-endogenous GPCR of step (b) is an amino acid sequence having the sequence of SEQ.ID.NO.:399.

### Claim 93 (depends on 1)

The method of claim 1 wherein the non-endogenous GPCR of step (b) is an amino acid sequence having the sequence of SEQ.ID.NO.:403.

### Claim 94 (depends on 1)

The method of claim 1 wherein the non-endogenous GPCR of step (b) is an amino acid sequence having the sequence of SEQ.ID.NO.:407.

### Claim 95 (depends on 1)

The method of claim 1 wherein the non-endogenous GPCR of step (b) is an amino acid sequence having the sequence of SEQ.ID.NO.:411.

### Claim 96 (depends on 1)

The method of claim 1 wherein the non-endogenous GPCR of step (b) is an amino acid sequence having the sequence of SEQ.ID.NO.:415.

### Claim 97 (depends on 1)

The method of claim 1 wherein the non-endogenous GPCR of step (b) is an amino acid sequence having the sequence of SEQ.ID.NO.:419.

### Claim 98 (depends on 1)

The method of claim 1 wherein the non-endogenous GPCR of step (b) is an amino acid sequence having the sequence of SEQ.ID.NO.:423.

### Claim 99 (depends on 1)

The method of claim 1 wherein the non-endogenous GPCR of step (b) is an amino acid sequence having the sequence of SEQ.ID.NO.:579.

### Claim 100 (depends on 1)

The method of claim 1 wherein the non-endogenous GPCR of step (b) is an amino acid sequence having the sequence of SEQ.I).NO.:581.

### Claim 101 (depends on 1)

The method of claim 1 further comprising the following step:
assessing, by using an endogenous ligand based assay, the impact of the non-endogenous compound of step (d) on the binding of an endogenous ligand for the known GPCR version of the non-endogenous version of said known GPCR of step (a) with said known GPCR.

### Claim 102 (depends on 101)

The method of claim 101 wherein said non-endogenous compound is an allosteric modulator of said known GPCR.
